Climb Bio, Inc. (CLYM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Climb Bio, Inc. (CLYM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $778.0M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 0.03 to the broader market. Climb Bio, Inc. Led by Aoife Brennan BCh MMSc, public since 2021-08-10.
Snapshot as of May 14, 2026.
- Spot Price
- $11.34
- Total OI
- 3.1K